We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+7.17%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$889M
AUM Growth
+$286M
(+47%)
Cap. Flow
+$257M
Cap. Flow
% of AUM
28.9%
Top 10 Holdings %
Top 10 Hldgs %
5.11%
Holding
1,751
New
702
Increased
366
Reduced
206
Closed
467
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$3.9M |
| 2 |
VAPO
Vapotherm, Inc. Common Stock
VAPO
|
+$3.76M |
| 3 |
Domino's
DPZ
|
+$3.52M |
| 4 |
Kroger
KR
|
+$3.43M |
| 5 |
DigitalBridge
DBRG
|
+$3.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vipshop
VIPS
|
+$4.82M |
| 2 |
Tencent Music
TME
|
+$4.56M |
| 3 |
Warner Bros
WBD
|
+$4.17M |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$4.13M |
| 5 |
Baidu
BIDU
|
+$4.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 20.25% |
| 2 | Healthcare | 14.82% |
| 3 | Industrials | 14.28% |
| 4 | Financials | 11.09% |
| 5 | Technology | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Puma Biotechnology
PBYI
$413M
| $137K | 0.02% |
+14,885
| New | +$151K |
|
1227
American Well
AMWL
$220M
| $136K | 0.02% |
+542
| New | +$156K |
|
|
NOVN
1228
DELISTED
Novan, Inc. Common Stock
NOVN
| $136K | 0.02% |
+13,565
| New | +$160K |
|
1229
Empire State Realty Trust
ESRT
$843M
| $130K | 0.01% |
+10,855
| New | +$128K |
|
|
GLOP
1230
DELISTED
GASLOG PARTNERS LP
GLOP
| $129K | 0.01% |
+35,090
| New | +$106K |
|
|
AGS
1231
DELISTED
PlayAGS
AGS
| $126K | 0.01% |
+12,715
| New | +$117K |
|
1232
RLX Technology
RLX
$2.43B
| $123K | 0.01% |
+14,078
| New | +$144K |
|
|
AXU
1233
DELISTED
Alexco Resource Corp
AXU
| $123K | 0.01% |
49,169
-254,064
| -84% | -$714K |
|
|
CASI
1234
DELISTED
CASI Pharmaceuticals
CASI
| $122K | 0.01% |
7,857
+6,213
| +378% | +$105K |
|
|
KA
1235
DELISTED
Kineta, Inc. Common Stock
KA
| $121K | 0.01% |
+1,481
| New | +$160K |
|
1236
Diamondrock Hospitality Co
DRH
$2.59B
| $118K | 0.01% |
12,170
-8,886
| -42% | -$89.3K |
|
|
PRTK
1237
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $118K | 0.01% |
+17,244
| New | +$139K |
|
1238
BeyondSpring
BYSI
$35.8M
| $117K | 0.01% |
11,174
-8,997
| -45% | -$94.9K |
|
1239
Indaptus Therapeutics
INDP
$167M
| $116K | 0.01% |
297
-122
| -29% | -$53.7K |
|
|
NNDM
1240
Nano Dimension
NNDM
$330M
| $116K | 0.01% |
14,119
-19,139
| -58% | -$142K |
|
1241
Moleculin Biotech
MBRX
$2.72M
| $114K | 0.01% |
+83
| New | +$113K |
|
1242
Root
ROOT
$783M
| $114K | 0.01% |
+584
| New | +$110K |
|
1243
NextCure
NXTC
$22.7M
| $113K | 0.01% |
1,177
-10,721
| -90% | -$1.1M |
|
1244
SFL Corp
SFL
$1.61B
| $112K | 0.01% |
+14,613
| New | +$120K |
|
1245
OraSure Technologies
OSUR
$275M
| $108K | 0.01% |
10,637
-13,388
| -56% | -$130K |
|
1246
CEL-SCI Corp
CVM
$28.1M
| $105K | 0.01% |
+405
| New | +$251K |
|
|
XELA
1247
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $101K | 0.01% |
11
+8
| +267% | +$55.6K |
|
1248
Comstock
LODE
$235M
| $97K | 0.01% |
+2,669
| New | +$103K |
|
|
RNTX
1249
Rein Therapeutics
RNTX
$67.4M
| $97K | 0.01% |
3,870
-281
| -7% | -$7.01K |
|
|
SOS
1250
SOS Limited
SOS
$14.5M
| $95K | 0.01% |
38
-11
| -22% | -$32.3K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q2 2021 Portfolio in Review
As of Q2 2021, GSA Capital Partners held 1,751 positions worth $889M, up 47% from $603M the previous quarter. Its ten largest holdings account for 5.1% of the portfolio.
GSA Capital Partners deployed $257M of net new capital in Q2 2021, opening 702 new positions and adding to 366 existing holdings. Its largest new stake was Vapotherm, Inc. Common Stock: 22,078 shares worth $4.17M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Baidu, an estimated $4.12M trimmed.
- GSA Capital Partners's largest Q2 2021 buy was Vapotherm, Inc. Common Stock: 22,078 shares worth $4.17M.
- GSA Capital Partners added most to Meta Platforms (Facebook) in Q2 2021, an estimated $3.9M increase.
- GSA Capital Partners's biggest Q2 2021 reduction was Baidu, cutting an estimated $4.12M.
- GSA Capital Partners fully exited Vipshop in Q2 2021, selling an estimated $4.82M.
- GSA Capital Partners's ten largest holdings make up 5.1% of its $889M portfolio in Q2 2021.
- GSA Capital Partners opened 702 new positions and closed 467 in Q2 2021.
- GSA Capital Partners's portfolio value rose 47% quarter-over-quarter to $889M.
Based on GSA Capital Partners's 13F filing for Q2 2021, filed 5 Aug 2021.